The JC polyomavirus (JCV) is ubiquitous in humans, infecting children asymptomatically, then persisting in renal tissue. Since JCV DNA can be readily isolated from urine, it should be a useful tool with which to study the evolution of DNA viruses in humans. We showed that JCV DNA from the urine of Japanese, Taiwanese, Dutch and German patients can be classified into A and B types, based upon restriction fragment length polymorphisms (RFLPs). This work was extended in the present study. We established multiple JCV DNA clones from the UK, Spain, Italy, Sweden, South Korea, People's Republic of China, Malaysia, Indonesia, Mongolia, India, Sri Lanka, Saudi Arabia, Ethiopia, Kenya, Zambia, South Africa and Ghana. Using typespecific RFLPs, most clones except the four clones from Ghana were classified as either type A or B. We constructed a molecular phylogenetic tree for the Ghanaian clones and several representative type A and B clones. According to the phylogenetic tree, the Ghanaian clones constituted a major new group, tentatively named type C. From the findings presented here and elsewhere, the following conclusions were drawn: (i) type A is prevalent only in Europe; (ii) type B is found mainly in Asia and Africa; and (iii) type C is localized to part of Africa. Our findings should help to clarify how JCV evolved in humans.
Introduction
JC polyomavirus (JCV) was first isolated in 1971 from the brain of a patient with progressive multifocal leukoencephalopathy (PML) (Padgett et al., 1971) . This virus, however, is ubiquitous in humans (Padgett & Walker, 1973 , 1976 , infecting children asympto-* Author for correspondence. Fax + 81 3 5449 5409. e-mail yogo@ims.u-tokyo.ac.jp
The DNA sequence data reported here have been deposited in the GSDB, DDBJ, EMBL and NCBI nucleotide sequence databases with the following accession numbers: regulatory region, D49987 (ET-5), D49988 (GH-1), D49989 (IN-l), D49990 (IN-3), D49991 (IT-l), D49992 (IT-3), D49993 (KE-6), D49994 (ML-1), D49995 (MO-2), D49996 (MO-8), D49997 (SA-3), D49998 (SO-I), D61696 (SL-1), D61697 (SW-1), D61698 (SW-2), D61699 (SW-3), D61700 (SW-4), D61701 (SW-7), D61702 (SW-8); VT-intergenic region, D43779 (GH-1), D43780 (GH-2), D43781 (GH-3), D43782 (GH-4). matically, then persisting in renal tissue (Chesters et al., 1983; Tominaga et al., 1992) . In adults, renal JCV replicates and generates progeny in urine (Kitamura et al., 1990 (Kitamura et al., , 1994 Since most adults excrete JCV DNA into their urine (Kitamura et al., 1994) , from which it can be readily isolated by molecular cloning or PCR (Yogo et aL, , 1991 Flaegstad et al., 1991 ; Markowitz et al., 1991) , JCV should be a useful tool with which to study the evolution of DNA viruses in humans. We previously showed that JCV DNA from the urine of Japanese, Taiwanese, Dutch and German patients can be classified into two types, A and B, on the basis of restriction fragment length polymorphisms (RFLPs) distributed throughout the genome (Yogo et al., 1991a) . This JCV DNA region (named VT-intergenic region) from 11 PML patients in the USA. According to the nucleotide variations at 20 sites in this region, they classified the 11 JCV isolates into types 1 and 2, which correspond to types A and B, respectively. [In this report we use the alphabetical nomenclature for JCV types, since a numerical system has been used to classify JCV regulatory regions (Walker & Frisque, 1986).] In this study, we further investigated the correlation between JCV types and geographical regions. In total, we established 124 clones from 18 regions. From the data in this study along with those of others, it can be concluded that type A is prevalent in Europe and that type B is distributed mainly in Asia and Africa. In addition, a new type was identified from Ghana by constructing a phylogenetic tree. These findings should have implications for the evolution of JCV in humans.
Methods
Urine. Urine specimens were collected from 18 geographical locations: London, UK; Rome, Italy; Stockholm, Sweden; Barcelona, Spain; Seoul, South Korea; Masai, Malaysia; Jakarta, Indonesia; Ulan Bator, Mongolia; Varanasi, India; Colombo, Sri Lanka; Riyadh, Saudi Arabia; Addis Ababa, Ethiopia; Nairobi, Kenya; Lusaka, Zambia; Welkom, South Africa; and Accra, Ghana. All donors were natives of each region and were aged over 40 years. All donors in India were Caucasian. The donors in each region were either volunteers or outpatients and none were immunosuppressed. Urine was collected from about 50 donors in each region and stored at -20 °C until the required number of specimens was collected. These were then sent by air to the Department of Urology, Faculty of Medicine, University of Tokyo (Tokyo, Japan) where DNA was extracted as described (Kitamura et al., 1990) .
Cloning virus DNA. DNA from urine was screened for the presence of JCV DNA by PCR using primers JC-1L and JC-1R (Yogo et al., 1991 b) . This primer set was designed to detect both type A and B JCV DNA. The samples containing higher concentrations of JCV DNA were sent to the Department of Viral Infection (Institute of Medical Science, University of Tokyo) where JCV DNA was cloned into pUC 19 at the unique BamHI site as described (Yogo et al., 1991a) . Recombinant plasmids containing complete JCV DNA were prepared using the Wizard Midipreps DNA Purification System (Promega). The origins and types of JCV DNA clones that had previously been established and were used in this study are shown Table 1 .
Restriction analysis of virus DNA. Restriction enzymes were obtained from Toyobo (BamHI, BgllI, HaellI, HinclI, HindlII, Hinfl, NcoI and Pstl) and Takara Shuzo (EcoT14I). Digestion proceeded as recommended by the suppliers. Digested DNA was separated on a 1.5 or 
* Nucleotide numbers and coding regions were assigned according to Frisque et al. (1984) . ? Numbers of restriction sites are indicated in parentheses. , No restriction site.
1"8 % horizontal agarose gel or a 3.5 % polyacrylamide gel, depending upon the sizes of DNA fragments. HindIII fragments of lambda phage DNA or HinfI fragments of pUC19 were electrophoresed in parallel.
Sequencing of the regulatory region. A HindIII-NcoI fragment (the Ncol terminus was blunt-ended) that contained both the origin of replication and the regulatory region was isolated and inserted into M13mpl8 and M13mpl9 between the SmaI and HindIII sites. Singlestranded DNAs purified from recombinant phages were sequenced using the AutoRead Sequencing Kit and the ALFred DNA Sequencer (Pharmacia).
Sequencing of the VT-intergenie region. The VT-intergenic region [nucleotides (nt) 2131 to 2740; the nucleotide numbering system is that of Frisque et al., 1984] was amplified as described with modifications (Ault & Stoner, 1992; Kunitake et al., 1995) . The PCR mixture (50 lal) containing 0-1 to 0.3 ktg of cloned JCV DNA was amplified by 10 cycles at 94 °C for 1-5 rain, 55 °C for 1.5 min and 72 °C for 2.5 min using a TSR-300 Thermal Sequencer (lwaki Glass). Taq DNA polymerase and reagents were obtained from Takara Shuzo and used as recommended. The two primers, P-1 and P-2, have been described previously (Kunitake et al., 1995) . P-1 and P-2 carry HindIII and PstI sites at their 5' ends, respectively. The amplified fragments were cloned into pUC19 between the HindIII and PstI sites and purified recombinant plasmids were sequenced as described (Kunitake et al., 1995) . Both DNA strands were sequenced.
Determination of nucleotide changes responsible for type-determining
RFLPs. Of seven type-determining RFLPs (Table 2) , three (one of the BglII and both HinfI RFLPs) were located within the VT-intergenic region (Yogo et al., 1991 a) . The nucleotide changes responsible for these RFLPs have been identified by Ault & Stoner (1992) . The nucleotide changes responsible for the HincII RFLP were identified by a comparison of unpublished sequence data that we obtained during another study (Iida et al., 1993) . To determine the nucleotide changes responsible for the EcoT14I, HaeIII and one of the BglII RFLPs, we sequenced restriction fragments containing these RFLPs from three representative type B JCVs. Nucleotide changes responsible were then identified by comparing the data with the corresponding sequences of Mad-l, which is a typical type A JCV (Ault & Stoner, 1992; Yogo et al., 1991a) , the complete nucleotide sequence for which has been published (Frisque et al., 1984) .
Phylogenetic analysis. A neighbour-joining phylogenetic tree (Saitou & Nei, 1987) was constructed using the CLUSTAL V program (Higgins et al., 1992) . A neighbour-joining tree was also constructed using the ODEN program package (Ina, 1994 ; data not shown). Divergences were estimated by the two parameter method (Kimura, 1980) as well as the six parameter method (Gojobori et al., 1982) .
Results

Cloning JCV DNA from urine collected from various geographical regions
Urine was collected from natives of 18 geographical regions. DNA was extracted from the urine specimens and screened for JCV DNA in a laboratory where JCV DNA had never been cloned. The DNA samples containing higher concentrations of JCV DNA were sent to another laboratory where JCV DNA was cloned using a plasmid vector.
We established 124 JCV DNA clones in total. The number of clones per region ranged from two (Indonesia) to 12 (Mongolia) ( Table 3) . We designated the clones as shown in Table 3 .
Regulatory sequences of cloned JC V DNAs
There are two forms of JCV regulatory sequences, one (archetype) that can be detected in isolates from the urine as well as the kidney of non-PML individuals (Yogo et al., , 1991a Flaegstad et al., 1991; Markowitz et al., 1991; Tominaga et al., 1992) and one (PML type) that can be detected in isolates from the brains of PML patients (Martin et al., 1985; Matsuda et al., 1987 , Loeber & D6rries, 1988 Takahashi et al., 1992; Ault & Stoner, 1993; Yogo et al., 1994; Kato et al., 1994) . The former may have generated the latter during the course of persistence in patients (Yogo et al., , 1991 Iida et al., 1993; Ault & Stoner, 1993) . To confirm that the cloned JCV DNAs carry archetypal regulatory sequences, we sequenced the regulatory regions of representative clones from each geographical region. In Fig. 1 , the archetypal regulatory sequence of isolate CY and those identified here and previously (Yogo et al., 1991 a) are shown. Clones carrying each regulatory sequence are shown in Table 4 .
We identified many novel sequences in this study, although some known sequences (Fig. 1 , sequences 1, 2, 6 and 20; Yogo et al., 1991a) were also detected. Sequences 3, 4 and 28 (Yogo et al., 1991a) were not found in this study. The features of the sequences ( Fig. 1) can be summarized as follows: (i) 1 to 3nt were substituted in sequences 2 through 15; (ii) 2nt were substituted and 1 nt was inserted in sequence 16; (iii) segments ranging from 2 to 23 nt were deleted from sequences 17 to 23; (iv) 1 to 3 nt were substituted and 2 to 11 nt were deleted in sequences 24 to 27; (v) a 13 nt Fig. 1 . Regulatory DNA sequences of JCV isolates molecularly cloned from urine collected from various geographical regions. The nucleotide sequences from HindIII cleavage sites to the start sites of late leader protein LP1 (agnoprotein) were determined for representative isolates from each geographical region. These, together with known sequences (Yogo et al., , 1991a , are shown. Clones carrying each regulatory sequence are shown in Table 4 . Sequence 1 on the top line is the CY archetypal regulatory sequence . For the other sequences, the same nucleotide as that shown in sequence 1 is indicated by a dash, with point mutations indicated. Gaps with parentheses indicate deletions relative to sequence 1. The origin of replication (Ori; Frisque et al., 1984) , TATA box sequence and several motifs resembling consensus transcription element-binding sites (Ault & Stoner, 1993; Wegner et al., 1993) are indicated above sequence 1. Fig. 1 . ? Clones established previously are underlined (see Table 1 ).
segment was duplicated in sequence 28; (vi) 2 nt were substituted and the 13 nt segment was duplicated in sequence 29. The above data show, without exception, that the JCV DNAs derived from the urine collected from various regions carry the archetypal regulatory sequence or regulatory sequences which deviate slightly from the archetype. Thus, JCV isolates with the archetypal regulatory sequence (or carrying sequences deviating slightly from it) are spread worldwide.
Although almost half (13 of 29) of the regulatory sequences (Fig. 1) contained deletions or duplications; the lengths of the deleted and duplicated segments were relatively short compared with the lengths of deleted and duplicated segments in PML type regulatory regions. Furthermore, none of the clones carried both a deletion and a duplication. Accordingly, we concluded that JCVs with PML type regulatory sequences which have extensive sequence rearrangements (Martin et al., 1985; Matsuda et al., 1987; Loeber & Domes, 1988; Takahashi et al., 1992; Ault & Stoner, 1993; Yogo et al., 1994; Kato et al., 1994) do not circulate in the human population.
The archetypal regulatory region contains several motifs resembling consensus transcription elements (Ault & Stoner, 1993; Wegner et al., 1993) . These motifs are indicated above sequence 1 in Fig. 1 . Most deleted segments did not contain any of these, with the exception of the segment deleted from sequence 18, which contained the origin-proximal Sp-1 motif. These data imply that most of the motifs indicated in Fig. 1 , except the origin-proximal Sp-I motif, have been conserved in the course of JCV evolution. It remains to be examined whether these motifs are essential for JCV replication in humans.
Typing of JC V DNA clones by RFLP
We reported that nine restriction enzymes produced type-determining RFLPs (Yogo et al., 1991a ). An examination of the nucleotide sequences involved in these RFLPs showed that some were caused by the same nucleotide changes. For example, one of the HinfI RFLPs and the Cfrl3I RFLP arose from the same change at nt 2386. Consequently, we identified seven independent type-determining RFLPs that were produced by the five restriction enzymes listed in Table 2 .
We digested the 124 clones established in this study with each of the five restriction enzymes. Before digestion, JCV DNA was excised and isolated from the vector to facilitate detection of the respective virus DNA fragments. The digested DNAs were separated on 1"5 or 1.8 % agarose or 3.5 % polyacrylamide gels. Comparing the fragment profiles between each JCV DNA cloned here and the reference JCV DNA of type A (G2; Yogo et al., 1991a) and B (CY; Yogo et al., 1990) , we determined the presence or absence of the seven typespecific restriction sites. The results of these analyses are shown in Table 5 and can be summarized as follows: (i) Most clones from Europe (UK, Italy, Spain and Sweden) showed the type A phenotype in all seven RFLPs. One clone from Sweden showed the type B phenotype in all RFLPs.
(ii) Most of the clones from East Asia (South Korea, China, Malaysia and Indonesia) showed the type B phenotype in all seven RFLPs. Exceptions included one sample from South Korea and one from China (Wuhan). The former showed the type A phenotype in all RFLPs, whereas the latter showed the type B phenotype in most RFLPs except that of HincII. From the above data, we concluded that most of the clones from Europe except one from Sweden were type A (the rare clone was type B), that most of the clones from Asia except one from South Korea were type B (the rare clone was type A) and that all the clones from the eastern and southern parts of Africa were type B. However, the type of the four Ghanaian clones was not clear, although they had a bias for type B. Therefore, we further analysed these clones.
Phylogenetic analysis of the clones from Ghana
Phylogenetic analysis by the neighbour-joining method (Saitou & Nei, 1987) 
FM-°2
IM-03 M-04 1% Diversity Fig. 2 . Neighbour-joining tree of JCV VT-intergenic regions. The tree shows analysis of the four Ghanaian clones (GH-1 to -4) and 19 other available published sequences including seven clones from the urine of healthy Japanese volunteers (C-01 to -03, M-01 to -04; Knnitake et aL, 1995) and 12 clones from the brains of American PML patients (Mad-1, 101 to 106, 201 to 205; Frisque et aL, 1984; Ault & Stoner, 1992). 19 JCV DNA clones whose VT-intergenic sequences were known. These included seven clones from the urine of healthy Japanese volunteers (Kunitake et al., 1995) and 12 clones from the brains of American PML patients (Frisque et aL, 1984; Ault & Stoner, 1992) . According to the resultant phylogenetic tree (Fig. 2) , the 23 clones were classified into three major branches: type A, which comprised Mad-1 and 101 through 106; type B, which comprised M-01 through M-04, C-01 through C-03 and 202 through 205; and a further type that contained all the Ghanaian clones and 201.
A phylogenetic tree was also constructed using data from part of the VP1 gene (nt 2131 to 2533) to examine the relationship among the Ghanaian clones and 25 JCV DNA clones from various geographical regions. The latter included, in addition to the 12 USA clones used previously (Fig. 2) , four clones from Japan, four from the USA, two from Germany, two from the Netherlands and one from Taiwan (Iida et al., 1993) . The resulting phylogenetic tree (data not shown) also indicated the existence of the third major group that contained all the Ghanaian clones and 201.
In a phytogenetic tree based on maximum parsimony analysis (data not shown), the overall branching pattern was very similar to that obtained by neighbour-joining analysis.
Discussion
We have established JCV DNA clones from nine regions in Asia, five in Africa and four in Europe. We classified them according to seven RFLPs which were distributed throughout the genome (Yogo et al., 1991a) . Most clones showed the same phenotype (type A or B) in all or six of the seven RFLPs, and therefore were classified as type A or B. However, for the four clones from Ghana, the number of RFLPs with the type B phenotype did not differ significantly from that of RFLPs with the type A phenotype. We therefore further analysed these clones according to the phylogenetic method. We concluded that these clones, together with strain 201 (Ault & Stoner, 1992) , constitute a new type (tentatively named type C) belonging to neither type A nor B.
Nevertheless, Ault & Stoner (1992) classified strain 201 into type B on the basis of the nucleotides at typedetermining sites within the VT-intergenic region, although 201 showed type A-specific nucleotides at some of the sites. This disagreement implies that typing of JCV based upon type-determining sites may not reflect the actual type, unless the phenotypes at most typedetermining sites are consistent.
Data from other studies regarding the JCV types in Europe are available: (i) five and three JCV DNA clones from Germany and the Netherlands, respectively, were classified into type A (Yogo et al., 1991 a) ; (ii) two clones from the Netherlands were classified into type B (Yogo et al., 1991 a) ; (iii) two sister clones (GS-K/GS-B) from a German PML patient (Loeber & D6rries, 1988) were type B (Ault & Stoner, 1992; Yogo et aL, 1991 a) ; and (iv) four and two JCV DNAs (PCR-amplified fragments) from Norway and Denmark, respectively (Flaegstad et al., 1991) , were judged to be type A (Yogo et al., 1991 a) . Furthermore, all JCV DNA clones from Japan and Taiwan were type B (Yogo et al., 1991 a) .
Excluding the JCVs spread in America (see below), we obtained the following general conclusions from the findings presented here and elsewhere: (i) type A is prevalent only in Europe; (ii) type B is found mainly in Asia and Africa; and (iii) type C is localized to part of Africa. Examples that contradict the above rules are discussed below.
One clone in South Korea (SK-6) did not fit the above rule. We therefore examined the history of the urine donor (male, aged 35 years) from whom this clone was established. He had lived in the USA for three years. He may have been infected with a type A strain during his stay in the USA, since both type A and type B strains are prevalent in the USA (Ault & Stoner, 1992 (Yogo et al., 1991 a, Ault & Stoner, 1992 . This is because they can be distinguished from Asian and African type B JCV by molecular phylogenetic (Iida et al., 1993) and RFLP analysis (data not shown). Which local human populations in Europe are infected with the type B JCV strains remains to be studied.
At present, the type of JCV spread among natives of the USA is unknown. However, according to the distribution of JCV types in other geographical regions, almost all JCV types should be prevalent in the USA, since most present-day Americans are the descendants of the emigrants from Europe, Asia and Africa. In fact, Ault & Stoner (1992) have detected both type A and type B JCVs in American PML patients. However, one strain (201), which they assigned to type B, and the four JCV isolates from Ghana constituted type C. Strain 201 may originate from a JCV strain that was introduced to America by an African who was brought as a slave from West Africa about 200 years ago. The association of strain 201 with type C suggests that in general, the origin of a local human population can be traced by analysing the prevalent JCV sequences and by connecting them with those found in other geographical regions.
Some features of JCV transmission have been elucidated: (i) JCV infects only humans (Padgett & Walker, 1976) ; (ii) most humans are infected with JCV (Padgett & Walker, 1973 , 1976 ; (iii) JCV is transmitted frequently from parents to children (Kunitake et al., 1995); and (iv) humans are resistant to superinfection with JCV (Kitamura et al., 1994) . These features of transmission may have allowed JCV to associate with humans since the establishment of JCV as a unique virus species. This association may have generated the correlation between JCV types and human populations.
Recently, H.-U. Bernard and coworkers studied the diversity of the genome of human papillomavirus 16 (HPV-16) and HPV-18 among a number of virus isolates that were collected from various geographical regions (Ho et al., 1993; Ong et al., 1993) . From the patterns of HPV phylogeny, they concluded that HPV-16 and HPV-18 co-evolved with people of three major human races. We compared patterns of geographical distributions between JCV and HPVs:
(i) Type A JCV was nearly completely specific to Europeans. For HPV-16 as well as HPV-18, a cluster that contained all or most variants from Europeans was identified; however, isolates belonging to this cluster were also obtained from other ethnic groups.
(ii) Type C JCV was unique to Africans, while two HPV-16 clusters and one HPV-18 cluster, which were apparently unique to Africans, were identified.
(iii) Type B JCV was distributed mainly in Asia as well as in Eastern and Southern Africa. In addition, this type also occurred in Europe at a low frequency. On the other hand, fractions of the HPV-16 isolates from Asia and Americas formed an independent cluster and a subcluster within the European-specific cluster described above. Most HPV-18 isolates from Asia and Americas formed a single cluster within the European-specific cluster.
(iv) JCV isolates from India and Saudi Arabia were classified into type B, a type comprising essentially all Asian and East African isolates. However, HPV-16 isolates from similar regions and ethnic groups belonged to the European cluster.
Thus, there are both similarities and differences in the geographical and racial distributions between JCV and HPV. We postulated that the similarities reflected the coevolution of these viruses with human races. On the other hand, the dissimilarities may have arisen from the ancient transmission of the viruses among different ethnic groups. This transmission could have occurred as follows:
A virus (JCV or HPV) which is not essential for humans may have been lost in some ancient human populations. Such JCV-negative human populations may have come in contact with JCV-positive populations. Therefore, viruses in some human populations may represent the original viruses, but those in other populations may have been transmitted from different sources.
We are currently examining the phylogenetic relationship among JCVs in neighbouring geographical regions to elucidate whether original or transmitted JC¥ is prevalent in each human population.
